Proximal Arterial Occlusion in Acute Ischemic Stroke with Low NIHSS Scores Should Not Be Considered as Mild Stroke

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Kim, Joon Tae ^a,b   Park, Man Seok ^a   Chang, Jane ^a   Lee, Ji Sung ^c   Choi, Kang Ho ^a   Cho, Ki Hyun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

AGED; ARTERY OCCLUSION; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; FEMALE; FLUID ATTENUATED INVERSION RECOVERY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; RANKIN SCALE; RETROSPECTIVE STUDY; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; BRAIN ISCHEMIA; DISEASE PROGRESSION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84881568326     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070996     Document Type: Article

References (29)

1. Willey JZ, Stillman J, Rivolta JA, Vieira J, Doyle MM, et al. (2012) Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms. Int J Stroke 7: 202-206.
2. Khatri P, Conaway MR, Johnston KC, (2012) Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. Stroke 43: 560-562.
3. Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, et al. (2005) Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke 36: 2497-2499.
4. Rajajee V, Kidwell C, Starkman S, Ovbiagele B, Alger JR, et al. (2006) Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology 67: 980-984.
5. Kohrmann M, Nowe T, Huttner HB, Engelhorn T, Struffert T, et al. (2009) Safety and outcome after thrombolysis in stroke patients with mild symptoms. Cerebrovasc Dis 27: 160-166.
6. Kruetzelmann A, Siemonsen S, Gerloff C, Rosenkranz M, Rother J, et al. (2009) Thrombolysis targeting MRI defined tissue at risk in minor stroke. J Neurol Neurosurg Psychiatry 80: 1156-1158.
7. Siegler JE, Boehme AK, Kumar AD, Gillette MA, Albright KC, et al. (2012) What Change in the National Institutes of Health Stroke Scale Should Define Neurologic Deterioration in Acute Ischemic Stroke? J Stroke Cerebrovasc Dis.
8. Ferrari J, Knoflach M, Kiechl S, Willeit J, Schnabl S, et al. (2010) Early clinical worsening in patients with TIA or minor stroke: the Austrian Stroke Unit Registry. Neurology 74: 136-141.
9. Lee DK, Kim JS, Kwon SU, Yoo SH, Kang DW, (2005) Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke 36: 2583-2588.
10. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41.
11. Kwan J, Hand P, (2006) Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM 99: 625-633.
12. Ois A, Martinez-Rodriguez JE, Munteis E, Gomis M, Rodriguez-Campello A, et al. (2008) Steno-occlusive arterial disease and early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis 25: 151-156.
13. Coutts SB, Hill MD, Campos CR, Choi YB, Subramaniam S, et al. (2008) Recurrent events in transient ischemic attack and minor stroke: what events are happening and to which patients? Stroke 39: 2461-2466.
14. Nedeltchev K, Schwegler B, Haefeli T, Brekenfeld C, Gralla J, et al. (2007) Outcome of stroke with mild or rapidly improving symptoms. Stroke 38: 2531-2535.
15. Fischer U, Baumgartner A, Arnold M, Nedeltchev K, Gralla J, et al. (2010) What is a minor stroke? Stroke 41: 661-666.
16. Siegler JE, Boehme AK, Kumar AD, Gillette MA, Albright KC, et al. (2012) Identification of Modifiable and Nonmodifiable Risk Factors for Neurologic Deterioration after Acute Ischemic Stroke. J Stroke Cerebrovasc Dis.
17. DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ, (1999) Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke 30: 1208-1212.
18. Yong SW, Bang OY, Lee PH, Li WY, (2006) Internal and cortical border-zone infarction: clinical and diffusion-weighted imaging features. Stroke 37: 841-846.
19. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, et al. (2007) Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 6: 961-969.
20. Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, et al. (2010) Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 9: 489-497.
21. Dengler R, Diener HC, Schwartz A, Grond M, Schumacher H, et al. (2010) Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 9: 159-166.
22. Selim MH, Molina CA, (2010) Management of acute stroke patients with rapidly resolving deficits and persistent vascular occlusion: a real clinical equipoise. Stroke 41: 3007-3008.
23. Liebeskind DS, (2010) No-go to tissue plasminogen activator for transient ischemic attack. Stroke 41: 3005-3006.
24. Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, et al. (2012) Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Cerebrovasc Dis 34: 140-146.
25. Leigh R, Zaidat OO, Suri MF, Lynch G, Sundararajan S, et al. (2004) Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 35: 1903-1907.
26. Alvarez-Sabin J, Molina CA, Montaner J, Arenillas JF, Huertas R, et al. (2003) Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 34: 1235-1241.
27. Alvarez-Sabin J, Molina CA, Ribo M, Arenillas JF, Montaner J, et al. (2004) Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke 35: 2493-2498.
28. Martin-Schild S, Albright KC, Tanksley J, Pandav V, Jones EB, et al. (2011) Zero on the NIHSS does not equal the absence of stroke. Ann Emerg Med 57: 42-45.
29. Maas MB, Furie KL, Lev MH, Ay H, Singhal AB, et al. (2009) National Institutes of Health Stroke Scale score is poorly predictive of proximal occlusion in acute cerebral ischemia. Stroke 40: 2988-2993.